Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Caris Life Sciences Inc (NASDAQ: CAI) closed at $26.75 up 1.21% from its previous closing price of $26.43. In other words, the price has increased by $1.21 from its previous closing price. On the day, 0.7 million shares were traded. CAI stock price reached its highest trading level at $27.2 during the session, while it also had its lowest trading level at $26.34.
Ratios:
For a deeper understanding of Caris Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 20 ’25 when Denton John Russel bought 7,500 shares for $21.00 per share. The transaction valued at 157,500 led to the insider holds 123,591 shares of the business.
Brille Brian J bought 30,000 shares of CAI for $630,000 on Jun 20 ’25. The insider now owns 162,428 shares after completing the transaction at $21.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAI now has a Market Capitalization of 7434707456 and an Enterprise Value of 3575119360. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.76. Its current Enterprise Value per Revenue stands at 7.901 whereas that against EBITDA is -19.367.
Stock Price History:
Over the past 52 weeks, CAI has reached a high of $30.70, while it has fallen to a 52-week low of $25.56. The 50-Day Moving Average of the stock is -0.97%, while the 200-Day Moving Average is calculated to be -0.97%.
Shares Statistics:
For the past three months, CAI has traded an average of 5.13M shares per day and 4391966 over the past ten days. A total of 283.56M shares are outstanding, with a floating share count of 126.74M. Insiders hold about 7.30% of the company’s shares, while institutions hold 6.50% stake in the company.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
